LabCorp® announced that Covance Drug Development has relocated its clinical research unit in Dallas, TX, to a new, fit-for-purpose clinical research facility.
OmniComm Systems, a global provider of clinical data management technology and services, announced that it has signed a reselling partnership agreement with Tri-I Biotech Shanghai Inc.
Almac Group announced the successful completion of the Health Sciences Authority (HSA) inspection of its new Asia Pacific headquarters in Singapore.
Parexel announced expanded services and capabilities in model-based drug development (MBDD) through its Quantitative Clinical Development (QCD) group.
Certara®, a global biosimulation technology-enabled drug development company, announced the merger of its consulting group, Pharsight Consulting Services.